Baxter International (BAX) Gains from Investment Securities (2016 - 2025)
Baxter International (BAX) has disclosed Gains from Investment Securities for 17 consecutive years, with -$26.0 million as the latest value for Q2 2025.
- On a quarterly basis, Gains from Investment Securities fell 1400.0% to -$26.0 million in Q2 2025 year-over-year; TTM through Sep 2025 was -$44.0 million, a 980.0% decrease, with the full-year FY2020 number at -$86.0 million, changed N/A from a year prior.
- Gains from Investment Securities was -$26.0 million for Q2 2025 at Baxter International, down from -$6.0 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $44.0 million in Q3 2022 to a low of -$26.0 million in Q2 2025.
- A 5-year average of -$1.3 million and a median of -$8.0 million in 2021 define the central range for Gains from Investment Securities.
- Peak YoY movement for Gains from Investment Securities: soared 174.07% in 2021, then plummeted 1400.0% in 2025.
- Baxter International's Gains from Investment Securities stood at $20.0 million in 2021, then skyrocketed by 120.0% to $44.0 million in 2022, then crashed by 43.18% to $25.0 million in 2023, then crashed by 148.0% to -$12.0 million in 2024, then crashed by 116.67% to -$26.0 million in 2025.
- Per Business Quant, the three most recent readings for BAX's Gains from Investment Securities are -$26.0 million (Q2 2025), -$6.0 million (Q1 2025), and -$12.0 million (Q3 2024).